Compare MLCI & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLCI | SRTS |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | 21 | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.6M | 44.3M |
| IPO Year | N/A | 2016 |
| Metric | MLCI | SRTS |
|---|---|---|
| Price | $3.41 | $3.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 30.1K | ★ 34.5K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.68 | $2.66 |
| 52 Week High | $8.68 | $5.92 |
| Indicator | MLCI | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 52.56 | 54.29 |
| Support Level | $3.31 | $2.82 |
| Resistance Level | $3.84 | $3.11 |
| Average True Range (ATR) | 0.28 | 0.15 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 58.76 | 73.87 |
Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The company's reporting segments include asset management and insurance. The company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The Asset Management segment comprises all fee generating activities. The Insurance Solutions segment, which derives maximum revenue, consists of two product lines within the insurance business, LTC and MYGA.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.